The Beacon Aqueous Microshunt is an investigational device. This website will give a preview of what we hope Beacon will do for glaucoma sufferers after we’ve completed our clinical trial work and other testing.
PR Newswire MicroOptx Completes Patient Enrollment in Initial Phase of U.S. Pivotal Clinical Trial
Journal of Cataract and Refractive Surgery Ab Externo Device for the Treatment of Glaucoma
AOCOO 2020 Beacon Aqueous Microshunt – A Novel Way to Treat Glaucoma: Case Report
Ocular Surgery News Microshunt Moves Aqueous to Ocular Surface
DOC 2019 Prof. H. Burkhard Dick, M.D., Ph.D. on Early BAM Results
University of Minnesota 2019 Alumni Innovator Award
Eyewire News Zeiss Invests in MicroOptx
MINNEINNO Minnesota Cup Winner MicroOptx is Raising $16.8M
WDTN - Dayton, Ohio Doctor Hopes to Make History
CEOCFO Magazine Q&A with CEO Chris Pulling
University of St. Thomas Newsroom Alumnus Takes Grand Prize in MN Cup
Minneapolis/St. Paul Business Journal MicroOptx Raises $1.4M
Star Tribune MicroOptx Takes Top Spot in MN Cup
Star Tribune Movers and Shakers
Ophthalmic Companies Showcase MicroOptx Presents
Minneapolis/St. Paul Business Journal Startup Snags $2.4M
